No resources found.
This briefing will focus on the value biosimilars hold for patient communities and our health care system. An overview of the resources available for increasing the understanding of biosimilars and the role they play in patient health will be provided. Discussion will address U.S. speed of adoption compared to European counterparts and explore the potential market barriers which can impede access to new treatment options for patients.
Read MoreThe National Health Council (NHC) recognizes the international nature of health care advocacy, even for patient groups that operate primarily in the United States. The NHC International Patient Forum: How the U.S. Patient Community Can Be Informed, Involved, and Influential in International Dialogues and Discussions, offers NHC patient group and nonprofit members the opportunity to share information and strategic thinking on international patient issues. The meeting is designed to set the stage for a broader discussion and prioritize international issues important to the patient community and determine next steps.
Read More